Friday, July 09, 2010
Health Canada says benefits of controversial diabetes drug still outweigh risks
TORONTO - Health Canada has waded into the controversy over the diabetes medication rosiglitazone, which is sold under the brand name Avandia....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment